These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21751552)

  • 1. [Intravenous immunoglobulin therapy for kidney diseases in children].
    Zwolińska D
    Pol Merkur Lekarski; 2011 Jun; 30(180):423-6. PubMed ID: 21751552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura (HUS/TTP) complicating adult Still's disease: remission induced with intravenous immunoglobulin G.
    Diamond JR
    J Nephrol; 1997; 10(5):253-7. PubMed ID: 9364316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inefficacy of intravenous immunoglobulin in patients with low-risk thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome.
    Finazzi G; Bellavita P; Falanga A; Viero P; Barbui T
    Am J Hematol; 1992 Nov; 41(3):165-9. PubMed ID: 1415190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of an infant with severe acute refractory immune thrombocytopenic purpura using combination therapy including rituximab.
    Iesato K; Hatakeyama N; Yamamoto M; Hori T; Inazawa N; Tsutsumi H; Suzuki N
    Pediatr Blood Cancer; 2009 Aug; 53(2):203-5. PubMed ID: 19301247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic microangiopathy and intravenous immunoglobulin therapy.
    Watanabe T
    Pediatr Nephrol; 2007 Jun; 22(6):907-8; author reply 909. PubMed ID: 17295029
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of thrombotic microangiopathies].
    Debourdeau P; Zammit C; Souleau B; Védrine L; Farge-Bancel D
    Ann Med Interne (Paris); 1999 Sep; 150(5):374-87. PubMed ID: 10544747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both.
    Gereige RS; Barrios NJ
    P R Health Sci J; 2000 Mar; 19(1):15-8. PubMed ID: 10761200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of IVIG action in immune thrombocytopenic purpura.
    Hansen RJ; Balthasar JP
    Clin Lab; 2004; 50(3-4):133-40. PubMed ID: 15074465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics and outcome of Chinese patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a 9-year retrospective study.
    Zhang W; Shi H; Ren H; Shen PY; Pan XX; Li X; Chen YX; Xu YW; Chen XN; Zhu P; Chen N
    Nephron Clin Pract; 2009; 112(3):c177-83. PubMed ID: 19439988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kidney diseases associated with hemolytic uremic syndrome,thrombotic thrombocytopenic purpura and disseminated intravascular coagulation].
    Naruse T
    Nihon Naika Gakkai Zasshi; 1992 Jan; 81(1):73-6. PubMed ID: 1556467
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemically dimerized intravenous immunoglobulin has potent ameliorating activity in a mouse immune thrombocytopenic purpura model.
    Machino Y; Suzuki E; Higurashi S; Ohta H; Suzuki M; Kohroki J; Masuho Y
    Biochem Biophys Res Commun; 2012 Feb; 418(4):748-53. PubMed ID: 22306012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A patient with Crohn's disease who presented with thrombotic thrombocytopenic purpura/hemolytic uremic syndrome.
    Unverdi S; Ceri M; Öztürk MA; Akbal E; Ensari A; Yılmaz R; Kocak E; Inal S; Koklu S; Duranay M
    Ren Fail; 2011; 33(2):244-5. PubMed ID: 21332348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weekly long-term intravenous immunoglobulin for refractory parvovirus B19 and Epstein-Barr virus-induced immune thrombocytopenic purpura.
    Tavil B; Unal S; Aytaç-Elmas S; Yetgin S
    Turk J Pediatr; 2008; 50(1):74-7. PubMed ID: 18365597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renal manifestations and outcome of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in adults.
    Conlon PJ; Howell DN; Macik G; Kovalik EC; Smith SR
    Nephrol Dial Transplant; 1995; 10(7):1189-93. PubMed ID: 7478122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical hemolytic uremic syndrome responsive to steroids and intravenous immune globulin.
    Watt T; Warshaw B; Katzenstein HM
    Pediatr Blood Cancer; 2009 Jul; 53(1):90-1. PubMed ID: 19301397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemolytic uraemic syndrome with peripheral gangrene and Kawasaki disease in a 15-month-old child.
    Krishnamurthy S; Jagadeesh A; Chandrasekaran V; Mahadevan S; Rajesh NG
    Paediatr Int Child Health; 2017 Feb; 37(1):70-73. PubMed ID: 26752398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders.
    Emmi L; Chiarini F
    Neurol Sci; 2002 Apr; 23 Suppl 1():S1-8. PubMed ID: 12032582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpura.
    Xie F; Blackhouse G; Assasi N; Campbell K; Levin M; Bowen J; Tarride JE; Pi D; Goeree R
    Clin Ther; 2009 May; 31(5):1082-91; discussion 1066-8. PubMed ID: 19539109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children.
    Tarantino MD; Young G; Bertolone SJ; Kalinyak KA; Shafer FE; Kulkarni R; Weber LC; Davis ML; Lynn H; Nugent DJ;
    J Pediatr; 2006 Apr; 148(4):489-94. PubMed ID: 16647411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful management with intravenous immunoglobulins in alemtuzumab-induced acute inflammatory demyelinating neuropathy: clinical report of three patients.
    Castelli R; Gritti G; Cannavò A; Moreo G; Conti G; Reda G; Cortelezzi A
    Immunopharmacol Immunotoxicol; 2012 Aug; 34(4):717-20. PubMed ID: 22208918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.